I have a long-standing track record in the field of biomaterials interrface science. I hold the position of Research Leader and Emeritus Professor, having also been Director of the Mawson Institute until late 2015. I have applied my materials science expertise to research at the interface between materials and biological systems (“biomaterials interface science”) for 28 years. I have specialised in strategies utilising surface modification and coating technologies for modifying existing materials and biomedical devices to improve bio-interfacial responses for various applications in human health care and biotechnology. I am also known internationally for work on the development and application of modern physico-chemical and... Read more
About me
I have a long-standing track record in the field of biomaterials interrface science. I hold the position of Research Leader and Emeritus Professor, having also been Director of the Mawson Institute until late 2015. I have applied my materials science expertise to research at the interface between materials and biological systems (“biomaterials interface science”) for 28 years. I have specialised in strategies utilising surface modification and coating technologies for modifying existing materials and biomedical devices to improve bio-interfacial responses for various applications in human health care and biotechnology. I am also known internationally for work on the development and application of modern physico-chemical and spectroscopic methods for the characterization and mechanistic molecular understanding of biomaterials surfaces and their interfacial interactions with proteins, cells and bacteria. In recent years rationally designed thin coatings to prevent the attachment and biofilm formation of bacteria and fungi have been a major focus of my group’s research efforts. Of particular interest is the question how bacterial and fungal cells interact with antibiotics bound onto solid materials surfaces.
I have also established a solid reputation for effectiveness in translating research outcomes to products. My most notable achievement was my major role in the development of the first viable extended-wear contact lens, Ciba Vision Focus Night&Day, which has enjoyed enormous commercial success. I am a co-inventor on 21 distinct patents. My contributions to the biomaterials field have led to nominations to honorary positions such as President of the Australian Society for Biomaterials for the years 2000, 2001, and 2003, Division Chair of the Biomaterials Interfaces Division of the US AVS Technology Society in 2004, and appointments as Visiting Professor at UNSW and at the ETH Zürich, Switzerland.
About me
Doctor of Philosophy ETH Zurich
Diploma in Chemistry ETH Zurich
Diploma in Education ETH Zurich
Research
Excludes commercial-in-confidence projects.
ARC Hub Processing Advanced Lignocellulosics Products (PALS), ARC - Industrial Transformation Research Hubs, 01/01/2018 - 31/12/2024
Combating fungal biofilm growth on surfaces, ARC - Discovery Projects, 17/03/2015 - 31/07/2020
Order from chaos: Rational design of biointerfacing plasma polymer coatings, ARC - Discovery Projects, 01/01/2016 - 30/09/2019
Novel plastics using renewable signal chemistry to remove bacteria in water, ARC - Linkage Project, 01/07/2015 - 28/06/2019
Mechanisms of Interaction and Therapeutic Strategies for Polymicrobial Biofilms, NHMRC - Project Grant, 14/05/2014 - 31/12/2017
Development and evaluation of novel antibacterial coatings, ARC - Linkage Project, 28/06/2013 - 31/12/2017
Development of antibacterial and anti-inflammatory compounds, Wound Management Innovation CRC, 01/09/2013 - 31/12/2016
Applying biocompatible coatings on LCP polymer Nanopatches and characterising (including wetting), Vaxxas Pty Ltd, 26/09/2016 - 31/12/2016
RP2.13 - Optimised serrulatane bioactives from Eremophila plants, Wound Management Innovation CRC, 01/07/2013 - 30/12/2016
Research
Research outputs for the last seven years are shown below. Some long-standing staff members may have older outputs included. To see earlier years visit ORCID, ResearcherID or Scopus
Open access indicates that an output is open access.
Year | Output |
---|---|
2016 |
5
|
2013 |
7
|
2012 |
5
|
2011 |
|
2009 |
|
Year | Output |
---|---|
2024 |
Open access
1
1
2
|
2023 |
Open access
1
1
|
2022 |
1
1
|
2022 |
Open access
18
18
|
2022 |
Open access
|
2021 |
4
4
|
2021 |
Open access
24
22
|
2021 |
1
1
|
2021 |
2
2
|
2021 |
Open access
4
4
|
2020 |
11
10
5
|
2020 |
Open access
13
12
|
2020 |
2
2
|
2020 |
Open access
5
5
1
|
2019 |
Open access
15
11
1
|
2019 |
Open access
3
|
2019 |
Open access
8
9
3
|
2019 |
Open access
13
12
|
2019 |
Open access
3
4
|
2019 |
45
43
|
2019 |
Open access
6
5
|
2018 |
Open access
56
56
|
2018 |
Open access
47
43
|
2018 |
13
11
|
2018 |
Open access
2
2
|
2018 |
Open access
6
8
|
2018 |
Open access
12
11
|
2018 |
Open access
128
121
|
2017 |
5
5
1
|
2017 |
Open access
34
31
|
2017 |
Open access
15
15
|
2017 |
Open access
17
17
|
2017 |
Open access
13
13
|
2017 |
Open access
3
3
|
2017 |
Open access
7
9
|
2016 |
Open access
16
14
32
|
2016 |
Open access
46
42
|
2016 |
Open access
27
24
|
2016 |
Open access
5
5
|
2016 |
28
26
|
2016 |
Open access
10
9
|
2016 |
Open access
15
15
|
2015 |
17
13
|
2015 |
Open access
25
25
2
|
2015 |
31
30
|
2015 |
Open access
24
26
|
2015 |
Open access
|
2015 |
Open access
8
8
|
2015 |
Open access
121
112
|
2015 |
Open access
39
36
|
2015 |
Open access
22
22
19
|
2015 |
Open access
29
23
|
2015 |
Open access
21
21
|
2015 |
8
8
|
2015 |
60
57
|
2014 |
3
3
|
2014 |
12
12
|
2014 |
6
6
|
2014 |
7
7
|
2014 |
23
22
|
2014 |
Open access
25
22
|
2014 |
94
90
|
2014 |
46
41
|
2014 |
17
17
|
2014 |
21
20
|
2014 |
71
67
3
|
2014 |
21
22
|
2014 |
Open access
16
16
|
2014 |
54
50
|
2014 |
47
42
1
|
2013 |
10
10
|
2013 |
86
75
|
2013 |
65
59
|
2013 |
31
30
|
2013 |
189
181
|
2013 |
16
15
|
2013 |
39
33
|
2013 |
Open access
17
16
|
2013 |
22
22
|
2013 |
19
18
|
2013 |
Open access
4
3
|
2013 |
Open access
32
33
|
2012 |
Open access
23
21
|
2012 |
Open access
37
34
|
2012 |
7
7
|
2012 |
54
53
|
2012 |
34
34
|
2012 |
14
14
|
2012 |
9
9
|
2012 |
10
10
|
2012 |
16
14
|
2012 |
10
11
|
2012 |
32
30
|
2012 |
20
20
|
2012 |
36
33
|
2011 |
Open access
20
20
|
2011 |
14
14
|
2011 |
9
10
|
2011 |
13
12
|
2011 |
88
79
|
2011 |
34
32
|
2011 |
63
61
|
2011 |
Open access
146
135
|
2011 |
57
52
|
2010 |
12
11
|
2010 |
20
20
|
2010 |
31
28
|
2010 |
38
38
|
2010 |
1
|
2010 |
100
95
|
2010 |
88
80
|
2010 |
150
139
|
2010 |
79
71
|
2010 |
55
49
|
2009 |
18
20
|
2009 |
413
394
|
2009 |
97
90
|
2009 |
70
61
|
2009 |
8
6
|
2009 |
51
48
|
2009 |
32
28
|
2009 |
99
96
|
2009 |
11
11
|
2009 |
446
404
|
2009 |
109
96
|
2008 |
18
14
|
2008 |
46
44
|
2008 |
42
41
|
2008 |
87
84
|
2008 |
37
34
|
2008 |
84
79
|
2008 |
Open access
|
2008 |
18
16
|
2008 |
|
2008 |
Open access
6
4
|
2008 |
91
88
|
2008 |
84
73
|
2008 |
71
66
|
Year | Output |
---|---|
2011 |
Open access
1
1
|
2010 |
5
7
|
2009 |
|
2008 |
|
2008 |
|
Research
Research
Details | Registry | Status |
---|---|---|
Griesser, Hans Jörg; Ndi, Chi Pius; Semple, Susan Jean; Ys, Hardi |
WO | Filed |
Metal ion binding polymers and uses thereof Nyden, Bo Magnus; Nann, Thomas; Griesser, Hans Jorg; Coad, Bryan; Larsson, Mikael; Linden, Johan Benny |
WO | Filed |
External engagement & recognition
Organisation | Country |
---|---|
Aarhus University | DENMARK |
Asemblon Inc | AUSTRALIA |
Australian National University | AUSTRALIA |
Australian Nuclear Science and Technology Organisation | AUSTRALIA |
Austrian Institute of Technology | AUSTRIA |
CeramiSphere Pty Ltd | AUSTRALIA |
CRC | AUSTRALIA |
CSIRO Australia (Commonwealth Scientific Industrial Research organisation) | AUSTRALIA |
Department of Primary Industries, Parks, Water and Environment Tasmania | AUSTRALIA |
Ecole Polytechnique Federale de Lausanne | ITALY |
Edith Cowan University | AUSTRALIA |
Flinders University | AUSTRALIA |
Fraunhofer IGB | GERMANY |
Griffith University | AUSTRALIA |
Hanson Institute | AUSTRALIA |
Institute of Medical and Veterinary Science | AUSTRALIA |
Integria Healthcare | AUSTRALIA |
Johnson & Johnson | UNITED STATES |
Karlsruhe Institute of Technology | GERMANY |
Laboratoire de Biologie Moleculaire et de Genie genetique | BELGIUM |
Lancaster University | UNITED KINGDOM |
Leybold Optics | GERMANY |
Lulea University of Technology | SWEDEN |
Macquarie University | AUSTRALIA |
Mathys Orthopaedics Pty Ltd | AUSTRALIA |
Max Planck Institute for Biophysical Chemistry | GERMANY |
McGill University | CANADA |
Monash University | AUSTRALIA |
Montreal Heart Institute | CANADA |
National Mycology Reference Centre | AUSTRALIA |
Queensland University of Technology | AUSTRALIA |
Robert Mathys Stiftung | SWITZERLAND |
Royal Adelaide Hospital | AUSTRALIA |
SA Pathology | AUSTRALIA |
Schefenacker Vision Systems Australia Pty Ltd | AUSTRALIA |
Southern Cross University | AUSTRALIA |
Starpharma | AUSTRALIA |
Swinburne University of Technology | AUSTRALIA |
Swiss Federal Institute of Technology Lausanne | SWITZERLAND |
Swiss Federal Institute of Technology Zurich (ETH) | SWITZERLAND |
Tasmania Department of Primary Industries, Parks, Water and Environment, | AUSTRALIA |
Tasmanian Department of Primary Industries | AUSTRALIA |
The Alfred Hospital | AUSTRALIA |
The Australian Wine Research Institute | AUSTRALIA |
The University of Wollongong | AUSTRALIA |
Universita degli Studi di Pavia (AKA Institute for Advanced Study of Pavia) | ITALY |
Universite de Haute Alsace | FRANCE |
University College London | UNITED KINGDOM |
University Hospital Base | SWITZERLAND |
University of Adelaide | AUSTRALIA |
University of Bari | ITALY |
University of Bath | UNITED KINGDOM |
University of Canterbury | NEW ZEALAND |
University of Edinburgh | UNITED KINGDOM |
University of Erlangen-Nuremberg | GERMANY |
University of Freiburg | GERMANY |
University of Illinois at Urbana-Champaign | UNITED STATES |
University of Liverpool | UNITED KINGDOM |
University of Manchester | UNITED KINGDOM |
University of Melbourne | AUSTRALIA |
University of Montreal | CANADA |
University of New South Wales | AUSTRALIA |
University of Pavia | ITALY |
University of Queensland | AUSTRALIA |
University of Sheffield | UNITED KINGDOM |
University of Siegen | GERMANY |
University of South Australia | AUSTRALIA |
University of Sydney | AUSTRALIA |
University of Warwick | UNITED KINGDOM |
University of Washington | UNITED STATES |
University of Western Australia | AUSTRALIA |
University of Wollongong | AUSTRALIA |
Women's and Children's Hospital | AUSTRALIA |
Teaching & student supervision
Supervisions from 2010 shown
Thesis title | Student status |
---|---|
Amplification of surface plasmon resonance biomolecular binding events: towards improved biosensing based cancer prognostics | Completed |
Antibacterial coatings for biomedical devices by covalent grafting of serrulatane diterpenes | Completed |
Antibacterial serrulatanes: synthetic studies and structure-activity relationships | Completed |
Antimicrobial surface modification via plasma polymerization | Completed |
Biological actions of antibacterial compounds covalently attached onto solid material surfaces or released diffusively from materials | Completed |
Dendrimers interactions with lipid bilayers: mechanistic and kinetic studies | Completed |
Design and evaluation of blood-contacting coatings | Completed |
Discovery of antibacterial compounds from Australian Eremophila plants | Completed |
Effects of compositional grading and adhesion pre-treatments on the protective performance of microwave PECVD organosilicone coatings on transparent plastics | Completed |
High refractive index and semi-stepwise gradient refractive index coatings by plasma polymerisation | Completed |
Interplay of an antifungal coating and surface micro-cone structure on the biological responses of attaching fungal and mammalian cells | Completed |
Investigation of the activity of a caspofungin-grafted surface coating on attaching pathogenic fungi | Completed |
Long-range surface plasmon resonance biosensing structures for mammalian-cell studies | Completed |
Novel fabrication and operation of integrated silicon nanowire field effect biosensors for reliable detection of cancer prognostic biomarkers | Completed |
Role of molecular architecture on the properties of hybrid thin films | Completed |
Serrulatanes from eremophila neglecta: their spectrum of antibacterial activity, cytotoxicity and mode of action | Completed |
Strategies for combatting the formation of fungal biofilms on biomaterials surfaces | Completed |
Substrate effects on surface interactions at ultrathin polymer coatings | Completed |
Switchable coatings for protein-material interactions | Completed |